Afanat 30® Afatinib Tablets

Afanat 30 mg contains afatinib and is used to treat certain types of advanced or metastatic non-small cell lung cancer. Its main indications include EGFR mutation-positive NSCLC and selected cases of squamous NSCLC progressing after platinum-based chemotherapy.

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.